Key facts
- This page summarizes Ian Taylor's Form 4 filing for ARVINAS, INC. (ARVN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Feb 2025, 19:59.
Ian Taylor - 13 Feb 2025 Form 4 Insider Report for ARVINAS, INC. (ARVN)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- ARVN
- Reported as of
- 13 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Feb 2025, 19:59:01 UTC
- Prior SEC filing
- 27 Feb 2024
- Next SEC filing
- 25 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jared Freedberg, as attorney-in-fact for Ian Taylor
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ian Taylor filed Form 4 for ARVINAS, INC. (ARVN) on 18 Feb 2025.
Change
- Previous filing in this sequence was filed on 27 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ARVN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +20,619
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 168,141
- Date
- 13 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARVN
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +31,483
- Change %
- Price
- $0.000000
- Shares after
- 31,483
- Date
- 13 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,483
- Exercise price
- $17.67
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The restricted stock units (each, an "RSU") were granted by the issuer on February 13, 2025, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: 25% of the RSUs will vest on each of February 13, 2026, February 13, 2027, February 13, 2028 and February 13, 2029, subject to the reporting person's continued service with the Issuer on each vesting date.
Footnote F2
The option was granted by the Issuer on February 13, 2025, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award will vest on February 13, 2026, with the remainder of the shares vesting in equal monthly installments following February 13, 2026 through February 13, 2029, subject to the reporting person's continued service with the Issuer on each vesting date.